Researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers. The oral drug, called CYT387, was tested in mice as well as in human cells. In both ...

Previous therapies targeting specific genetic mutations have had mixed results across different cancer types. A new drug, larotrectinib, appears to work in all cancers with a mutation called a TRK ...

Leading cancer expert solve long-standing question of how various types of mutations in just one gene cause different types of diseases. Leading cancer experts at the University of Birmingham have ...

Despite the gazillions of hours (and possibly as many dollars) spent searching for a cure for cancer, none has emerged. This is primarily because every tumor has a different mutational profile and ...